Anonymous
Not logged in
Talk
Contributions
Create account
Log in
Search
Editing
Mary Ann Fletcher
(section)
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Namespaces
Page
Discussion
More
More
Page actions
Read
Edit
Edit source
History
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Notable studies in ME/CFS== *1994, Dysregulated expression of [[TNF-alpha|tumor necrosis factor]] in [[chronic fatigue syndrome]]: interrelations with cellular sources and patterns of soluble immune mediator expression<ref name="Patarca, 1994" /> [https://www.ncbi.nlm.nih.gov/pubmed/8148443 (Abstract)] *1995, Relationships of Cognitive Difficulties to Immune Measures, [[Depression]] and Illness Burden in [[Chronic Fatigue Syndrome]]<ref name="LutgendorfS, 1995" /> [http://www.tandfonline.com/doi/abs/10.1300/J092v01n02_03 (Abstract)] *1995, Physical symptoms of [[chronic fatigue syndrome]] are exacerbated by the stress of Hurricane Andrew<ref name="Lutgendorf, 1995" /> [https://www.ncbi.nlm.nih.gov/pubmed/7480560 (Abstract)] *1995, Dysregulated Expression of Soluble Immune Mediator Receptors in a Subset of Patients with [[Chronic Fatigue Syndrome]]: Cross-Sectional Categorization of Patients by Immune Status<ref name="Patarca, 1995" /> [http://www.tandfonline.com/doi/abs/10.1300/J092v01n01_06 (Abstract)] *1996, Interindividual Immune Status Variation Patterns in Patients with [[Chronic Fatigue Syndrome]]: Association with Gender and the [[TNF-alpha|Tumor Necrosis Factor]] System<ref name="Nancy Klimas, 1996" /> [https://www.tandfonline.com/doi/abs/10.1300/J092v02n01_03 (Abstract)] *1998, [[interleukin 6|Interleukin-6]] and Disease: Two Case Reports that Point to the Usefulness of Measuring [[Cytokine]] Levels in Clinical Settings<ref>[[Roberto Patarca]] & Mary Ann Fletcher. (1998). Interleukin-6 and Disease: Two Case Reports that Point to the Usefulness of Measuring Cytokine Levels in Clinical Settings. ''Journal of Chronic Fatigue Syndrome'', Vol. 4, Iss. 1, pp. 53-69. http://dx.doi.org/10.1300/J092v04n01_07</ref> [https://www.researchgate.net/publication/262838277_Interleukin-6_and_DiseaseTwo_Case_Reports_that_Point_to_the_Usefulness_of_Measuring_Cytokine_Levels_in_Clinical_Settings (Abstract)] *2000, Comparative Analysis of [[Lymphocytes]] in Lymph Nodes and Peripheral Blood of Patients with [[Chronic Fatigue Syndrome]]<ref name="Fletcher, 2000" /> [https://www.tandfonline.com/doi/abs/10.1300/J092v07n03_06 (Abstract)] *2000, Clinical and Immunologic Effects of Autologous Lymph Node Cell Transplant in [[Chronic Fatigue Syndrome]]<ref name="Klimas, 2000" /> [http://dx.doi.org/10.1300/J092v08n01_03 (Abstract)] *2000, Immunotherapy of [[Chronic Fatigue Syndrome]]: Therapeutic Interventions Aimed at Modulating the Th1/Th2 [[Cytokine]] Expression Balance<ref>{{Cite journal | last = Montero|first = Roberto Patarca | authorlink = Roberto Patarca-Montero | last2 = Klimas | first2 = Nancy G. | authorlink2 = Nancy Klimas | last3 = Fletcher | first3 = Mary Ann | author-link3 = Mary Ann Fletcher | date = 2000 | title = Immunotherapy of Chronic Fatigue Syndrome: Therapeutic Interventions Aimed at Modulating the Th1/Th2 Cytokine Expression Balance | url = |journal=Journal of Chronic Fatigue Syndrome|volume=8|issue=1 | pages = 3-37|doi=10.1300/J092v08n01_02|via=}}</ref> [http://dx.doi.org/10.1300/J092v08n01_02 (Abstract)] *2000, [[Chronic Fatigue Syndrome]]: Evidence Supporting the Hypothesis of a Behaviorally-Activated Neuromodulator of Fatigue<ref name="Hurwitz, 2000" /> [https://www.researchgate.net/publication/232072776_Chronic_Fatigue_SyndromeEvidence_Supporting_the_Hypothesis_of_a_Behaviorally-Activated_Neuromodulator_of_Fatigue (Abstract)] *2001, [[Cytokine]] and Other Immunologic [[Diagnostic biomarker|Markers]] in [[Chronic Fatigue Syndrome]] and Their Relation to Neuropsychological Factors<ref>{{Cite journal | last = Patarca-Montero|first = Roberto | author-link =Roberto Patarca-Montero | last2 = Antoni | first2 = Michael | authorlink2 = Michael Antoni | last3 = Fletcher | first3 = Mary Ann | author-link3 = Mary Ann Fletcher | last4 = Klimas | first4 = Nancy G. | author-link4 = Nancy Klimas | date = Mar 2001 | title = Cytokine and Other Immunologic Markers in Chronic Fatigue Syndrome and Their Relation to Neuropsychological Factors|url=http://www.tandfonline.com/doi/abs/10.1207/S15324826AN0801_7|journal=Applied Neuropsychology|language=en|volume=8|issue=1 | pages = 51–64|doi=10.1207/S15324826AN0801_7|issn=0908-4282|pmc=|pmid=|access-date=|quote=|via=}}</ref> - [https://www.tandfonline.com/doi/abs/10.1207/S15324826AN0801_7 (Abstract)] *2002, Effects of Benzalkonium Salts on G-protein-Mediated Processes and Surface Membranes: Relevance to Microbial- and Chemical-Induced Diseases<ref name="Patarca, 2002" /> [https://www.researchgate.net/publication/11980327_Benzalkonium_Salts_Effects_on_G_Protein-Mediated_Processes_and_Surface_Membranes (Abstract)] *2002, The Paul-Bunnell Heterophile Antibody Determinant in [[Epstein-Barr virus|Epstein-Barr Virus]]-Associated Disease<ref name="Patarca-Montero, 2002" /> [https://www.researchgate.net/publication/240741787_The_Paul-Bunnell_Heterophile_Antibody_Determinant_in_Epstein-Barr_Virus-Associated_Disease (Abstract)] *2007, Baseline [[Cortisol]] Levels Predict Treatment Outcomes in [[Chronic Fatigue Syndrome]] Nonpharmacologic Clinical Trial<ref name="Jason, Torres-Harding, 2007" /> [https://www.researchgate.net/profile/Leonard_Jason/publication/232042407_Baseline_Cortisol_Levels_Predict_Treatment_Outcomes_in_Chronic_Fatigue_Syndrome_Nonpharmacologic_Clinical_Trial/links/00b7d52f5229b2fa9f000000/Baseline-Cortisol-Levels-Predict-Treatment-Outcomes-in-Chronic-Fatigue-Syndrome-Nonpharmacologic-Clinical-Trial.pdf (Full Text)] *2008, The associations between basal salivary [[cortisol]] levels and illness symptomatology in [[chronic fatigue syndrome]]<ref name="Torres-Harding, 2008" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730359/ (Full text)] *2008, Evidence for T-helper 2 shift and association with illness parameters in [[chronic fatigue syndrome]] ([[chronic fatigue syndrome|CFS]])<ref name="Torres-Harding, Sorenson, 2008" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018761/ (Full Text)] *2009, Plasma [[cytokines]] in women with [[chronic fatigue syndrome]]<ref name="Fletcher, 2009" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779802/ (Full Text)] *2010, A Formal Analysis of [[Cytokine]] Networks in [[Chronic Fatigue Syndrome]]<ref name="Broderick, 2010" /> [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939140/ Full Text] *2010, Plasma neuropeptide Y: a [[biomarker]] for symptom severity in [[chronic fatigue syndrome]]<ref name="Fletcher, 2010" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024290/ (Full Text)] *2010, A Comparison of Immune Functionality in Viral versus Non-Viral [[chronic fatigue syndrome|CFS]] Subtypes<ref>{{Citation | last1 = Porter | first1 = Nicole | authorlink = Nicole Porter | last2 = Lerch | first2 = Athena | authorlink2 = | last3 = Jason | first3 = Leonard | authorlink3 = Leonard Jason | last4 = Sorenson | first4 = Matthew | authorlink4 = Matthew Sorenson | last5 = Fletcher | first5 = Mary Ann | authorlink5=Mary Ann Fletcher | last6 = Herrington | first6 = Joshua | authorlink6 = | title = A Comparison of Immune Functionality in Viral versus Non-Viral CFS Subtypes|journal = Journal of Behavioral and Neuroscience Research|volume=8|issue=2 | page = 1-8 | date = 2010 | pmid=24634898|doi= }}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951052/ (Full Text)] *2010, [[Biomarker]]s in Chronic Fatigue Syndrome: Evaluation of [[NKC|Natural Killer Cell]] Function and Dipeptidyl Peptidase IV/CD26<ref>{{Cite journal | last = Fletcher | first = Mary A. | authorlink = Mary Ann Fletcher | last2 = Zeng | first2 = Xiao R. | authorlink2 = | last3 = Maher | first3 = Kevin | author-link3 = | last4 = Levis | first4 = Silvina | authorlink4 = | last5 = Hurwitz | first5 = Barry | authorlink5 = | last6 = Antoni | first6 = Michael | authorlink6 = Michael Antoni | last7 = Broderick | first7 = Gordon | authorlink7 = Gordon Broderick | last8 = Klimas | first8 = Nancy G. | authorlink8 = Nancy Klimas | date = 2010-05-25 | editor-last = Unutmaz|editor-first = Derya | title = Biomarkers in Chronic Fatigue Syndrome: Evaluation of Natural Killer Cell Function and Dipeptidyl Peptidase IV/CD26|url=https://dx.plos.org/10.1371/journal.pone.0010817|journal=PLoS ONE|language=en|volume=5|issue=5| pages = e10817|doi=10.1371/journal.pone.0010817|issn=1932-6203|pmc=2876037|pmid=20520837|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876037/ (Full Text)] *2012, [[Biomarker]]s for chronic fatigue<ref name="Klimas, 2012" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373648/ (Full Text)] *2012, [[Cytokine]] expression profiles of immune imbalance in post-[[mononucleosis]] chronic fatigue<ref name="Broderick, 2012" /> [https://translational-medicine.biomedcentral.com/articles/10.1186/1479-5876-10-191 (Full Text)] *2014, Stress management skills, [[cortisol]] awakening response, and [[post-exertional malaise]] in [[Chronic Fatigue Syndrome]]<ref name="Hall, 2014" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165790/ (Full Text)] *2014, A Role for Homeostatic Drive in the Perpetuation of Complex Chronic Illness: [[Gulf War Illness]] and [[Chronic Fatigue Syndrome]]<ref>{{Citation | last1 = Craddock | first1 = Travis J.A. | authorlink1 = Travis Craddock | last2 = Fritsch | first2 = Paul | authorlink2 = | last3 = Rice, Jr | first3 = Mark A. | authorlink3 = | last4 = del Rosario | first4 = Ryan M. | authorlink4 = | last5 = Miller | first5 = Diane B. | authorlink5 = | last6 = Fletcher | first6 = Mary Ann | authorlink6 = Mary Ann Fletcher | last7 = Klimas | first7 = Nancy G. | authorlink7 = Nancy Klimas | last8 = Broderick | first8 = Gordon | authorlink8 = Gordon Broderick | title = A Role for Homeostatic Drive in the Perpetuation of Complex Chronic Illness: Gulf War Illness and Chronic Fatigue Syndrome | journal = PLOS One | volume = 9 | issue = 1 | page = e84839 | date = 2014 | pmid = | doi = 10.1371/journal.pone.0084839 }}</ref> [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0084839 (Full Text)] *2015, Perceived Fatigue Interference and Depressed Mood: Comparison of [[Chronic Fatigue Syndrome]]/[[Myalgic Encephalomyelitis]] Patients with Fatigued Breast Cancer Survivors<ref name="Hall, 2015" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500199/ (Full Text)] *2015, Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="KlimasNG, 2015" /> [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1023652 (Abstract)] *2015, Using [[gene expression]] signatures to identify novel treatment strategies in gulf war illness<ref>{{Cite journal | last = Craddock|first = Travis J.A. | last2 = Harvey | first2 = Jeanna M. | last3 = Nathanson | first3 = Lubov | last4 = Barnes | first4 = Zachary M. | last5 = Klimas | first5 = Nancy G. | last6 = Fletcher | first6 = Mary Ann | last7 = Broderick | first7 = Gordon | date = 2015-07-09 | title = Using gene expression signatures to identify novel treatment strategies in gulf war illness|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495687/|journal=BMC Medical Genomics|volume=8|doi=10.1186/s12920-015-0111-3|issn=1755-8794|pmc=4495687|pmid=26156520|issue=|pages=|quote= | author-link = Travis Craddock | authorlink2 = Jeanna Harvey | authorlink3 = Lubov Nathanson | authorlink4 = Zachary Barnes | authorlink5 = Nancy Klimas|via= | authorlink6 = Mary Ann Fletcher | authorlink7 = Gordon Broderick}}</ref> - [https://bmcmedgenomics.biomedcentral.com/articles/10.1186/s12920-015-0111-3 (Full text)] *2016, [[Sleep dysfunction|Poor sleep quality]] is associated with greater circulating pro-inflammatory [[cytokines]] and severity and frequency of [[ME/CFS|chronic fatigue syndrome/myalgic encephalomyelitis]] ([[CFS/ME]]) symptoms in women<ref name="Milrad, 2016" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5258835/ (Full Text)] *2016, Tracking post-infectious fatigue in clinic using routine Lab tests<ref name="Harvey, 2016" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847210/ (Full Text)] *2016, Illness progression in [[chronic fatigue syndrome]]: a shifting immune baseline<ref name="Russell, 2016" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785654/ (Full Text)] *2017, Telephone-administered versus live group cognitive behavioral stress management for adults with [[chronic fatigue syndrome|CFS]]<ref name="Hall, 2017" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270375/ (Full Text)] *2017, [[Depression]], evening salivary [[cortisol]] and [[inflammation]] in [[chronic fatigue syndrome]]: A psychoneuroendocrinological structural regression model<ref name="Milrad, 2017" /> [https://www.sciencedirect.com/science/article/abs/pii/S0167876017301629 (Abstract)] *2018, Identification of [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]]-associated DNA methylation patterns<ref>{{Cite journal | last = Trivedi|first = Malav S. | last2 = Oltra | first2 = Elisa | authorlink2 = Elisa Oltra | last3 = Sarria | first3 = Leonor | last4 = Rose | first4 = Natasha | last5 = Beljanski | first5 = Vladimir | last6 = Fletcher | first6 = Mary Ann | authorlink6 = Mary Ann Fletcher | last7 = Klimas | first7 = Nancy G. | authorlink7 = Nancy Klimas | last8 = Nathanson | first8 = Lubov | authorlink8 = Lubov Nathanson | date = Jul 2018 | title = Identification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-associated DNA methylation patterns|url=http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0201066|journal=PlosOne|volume=|pages=|doi=10.1371/journal.pone.0201066|via=}}</ref> - [[pubmed:30036399|(Full Text)]] *2019, From [[Diagnostic biomarker|biomarkers]] to targeted treatment: The myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and gulf war illness (GWI) story<ref>{{Cite journal | last = Klimas | first = N.G. | authorlink = Nancy Klimas | last2 = Fletcher | first2 = M.A. | authorlink2 = Mary Ann Fletcher | last3 = Abreu | first3 = M.M. | authorlink3 = | last4 = Aenlle | first4 = K. | authorlink4 = | last5 = Craddock | first5 = T. | authorlink5 = Travis Craddock | last6 = Broderick | first6 = G. | authorlink6 = Gordon Broderick | date = Feb 2019 | title = From biomarkers to targeted treatment: The myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and gulf war illness (GWI) story|url=https://linkinghub.elsevier.com/retrieve/pii/S0889159118311413|journal=Brain, Behavior, and Immunity|language=en|volume=76|issue=| pages = e40|doi=10.1016/j.bbi.2018.11.301|quote=|via=}}</ref> - [https://www.sciencedirect.com/science/article/pii/S0889159118311413?via%3Dihub (Abstract)] *2019, Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome<ref>{{Cite journal | last = Morris | first = Matthew C. | authorlink = Matthew Morris | last10 = Fletcher | first10 = Mary Ann | authorlink10 = Mary Ann Fletcher | last2 = Cooney | first2 = Katherine E. | authorlink2 = | last3 = Sedghamiz | first3 = Hooman | author-link3 = | last4 = Abreu | first4 = Maria | authorlink4 = | last5 = Collado | first5 = Fanny | authorlink5 = | last6 = Balbin | first6 = Elizabeth G. | authorlink6 = Elizabeth Balbin | last7 = Craddock | first7 = Travis J.A. | authorlink7 = Travis Craddock | last8 = Klimas | first8 = Nancy G. | authorlink8 = Nancy Klimas | last9 = Broderick | first9 = Gordon | authorlink9 = Gordon Broderick | date = Mar 2019 | title = Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome|url=https://linkinghub.elsevier.com/retrieve/pii/S0149291819301122|journal=Clinical Therapeutics|language=en|volume=|issue=|pages=|doi=10.1016/j.clinthera.2019.03.002|quote=|via=}}</ref> - [https://www.sciencedirect.com/science/article/abs/pii/S0149291819301122?via%3Dihub (Abstract)] *2019, Pharmaceutical Interventions in Chronic Fatigue Syndrome: A Literature-based Commentary<ref>{{Cite journal | last = Richman | first = Spencer | authorlink = | last2 = Morris | first2 = Matthew C. | authorlink2 = Matthew Morris | last3 = Broderick | first3 = Gordon | author-link3 = Gordon Broderick | last4 = Craddock | first4 = Travis J.A. | authorlink4 = Travis Craddock | last5 = Klimas | first5 = Nancy G. | authorlink5 = Nancy Klimas | last6 = Fletcher | first6 = Mary Ann | date = Mar 2019 | title = Pharmaceutical Interventions in Chronic Fatigue Syndrome: A Literature-based Commentary|url=https://linkinghub.elsevier.com/retrieve/pii/S0149291819300712|journal=Clinical Therapeutics|language=en|volume=|issue=|pages=|doi=10.1016/j.clinthera.2019.02.011|quote=|via= | authorlink6 = Mary Ann Fletcher}}</ref> - [[pubmed:30871727|(Abstract)]] *2019, Treatment Avenues in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Split-gender Pharmacogenomic Study of [[Gene expression|Gene-expression]] Modules<ref>{{Cite journal | last= Jeffrey|first = Mary G. | authorlink = | last2 = Nathanson | first2 = Lubov | authorlink2 = Lubov Nathanson | last3 = Aenlle | first3 = Kristina | author-link3 = | last4 = Barnes | first4 = Zachary M. | authorlink4 = Zachary Barnes | last5 = Baig | first5 = Mirza | authorlink5 = | last6 = Broderick | first6 = Gordon | authorlink6 = Gordon Broderick | last7 = Klimas | first7 = Nancy G. | authorlink7 = Nancy Klimas | last8 = Fletcher | first8 = Mary Ann | authorlink8 = Mary Ann Fletcher | last9 = Craddock | first9 = Travis J.A. | authorlink9 = Travis Craddock | date = Mar 2019 | title = Treatment Avenues in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Split-gender Pharmacogenomic Study of Gene-expression Modules|url=https://linkinghub.elsevier.com/retrieve/pii/S0149291819300475|journal=Clinical Therapeutics|language=en|volume=|issue=|pages=|doi=10.1016/j.clinthera.2019.01.011|quote=|via=}}</ref> - [[pubmed:30851951|(Abstract)]] *2019, Relationship satisfaction, communication self-efficacy, and chronic fatigue syndrome-related fatigue<ref>{{Cite journal | last = Milrad | first = Sara F. | authorlink = | last2 = Hall | first2 = Daniel L. | authorlink2 = | last3 = Jutagir | first3 = Devika R. | authorlink3 = | last4 = Lattie | first4 = Emily G. | authorlink4 = | last5 = Czaja | first5 = Sara J. | authorlink5 = | last6 = Perdomo | first6 = Dolores M. | authorlink6 = | last7 = Ironson | first7 = Gail | last8 = Doss | first8 = Brian D. | last9 = Mendez | first9 = Armando | last10 = Fletcher | first10 = Mary Ann | authorlink10 = Mary Ann Fletcher | last11 = Klimas | first11 = Nancy | authorlink11 = Nancy Klimas | last12 = Antoni | first12 = Michael H. | authorlink12 = Michael Antoni | date = Jul 2019 | title = Relationship satisfaction, communication self-efficacy, and chronic fatigue syndrome-related fatigue|url=https://linkinghub.elsevier.com/retrieve/pii/S0277953619303776|journal=Social Science & Medicine|language=en|volume=|issue=|pages=112392|doi=10.1016/j.socscimed.2019.112392|quote=|via=}}</ref> - [https://www.sciencedirect.com/science/article/abs/pii/S0277953619303776 (Abstract)] *2020, Unravelling myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Gender‐specific changes in the microRNA expression profiling in ME/CFS<ref name="Cheema2020">{{Cite journal | last = Cheema | first = Amanpreet K. | authorlink = | last2 = Sarria | first2 = Leonor | authorlink2 = | last3 = Bekheit | first3 = Mina | author-link3 = | last4 = Collado | first4 = Fanny | authorlink4 = Fanny Collado | last5 = Almenar‐Pérez | first5 = Eloy | authorlink5 = | last6 = Martín‐Martínez | first6 = Eva | authorlink6 = | last7 = Alegre | first7 = Jose | authorlink7 = José Alegre | last8 = Castro‐Marrero | first8 = Jesus | authorlink8 = Jesús Castro-Marrero | last9 = Fletcher | first9 = Mary A. | authorlink9 = Mary Ann Fletcher | date = Apr 14, 2020 | title = Unravelling myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Gender-specific changes in the microRNA expression profiling in ME/CFS|url=https://onlinelibrary.wiley.com/doi/abs/10.1111/jcmm.15260|journal=Journal of Cellular and Molecular Medicine|language=en|volume=00|issue=|pages=1-13|doi=10.1111/jcmm.15260|issn=1582-4934|pmc=|pmid=32291908|access-date=|quote=|via= | last10 = Klimas | first10 = Nancy | authorlink10 = Nancy Klimas | last11 = Oltra | first11 = Elisa | authorlink11 = Elisa Oltra | last12 = Nathanson | first12 = Lubov | authorlink12 = Lubov Nathanson}}</ref> - [https://onlinelibrary.wiley.com/doi/full/10.1111/jcmm.15260 (Full text)]
Summary:
Please make sure your edits are consistent with
MEpedia's guidelines
.
By saving changes, you agree to the
Terms of use
, and you irrevocably agree to release your contribution under the
CC BY-SA 3.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)
Navigation
Navigation
Skip to content
Main page
Browse
Become an editor
Random page
Popular pages
Abbreviations
Glossary
About MEpedia
Links for editors
Contents
Guidelines
Recent changes
Pages in need
Search
Help
Wiki tools
Wiki tools
Special pages
Page tools
Page tools
User page tools
More
What links here
Related changes
Page information
Page logs